Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Simpson-Yap

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
The Lancet. Diabetes & Endocrinology|April 2, 2021
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trialsDavid A Jolliffe, Carlos A Camargo, John D Sluyter, et al.
Neurology|October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple SclerosisSteve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trialsDavid A Jolliffe, Carlos A Camargo, John D Sluyter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 SeveritySteve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
The Lancet. Diabetes & Endocrinology|February 24, 2025
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate dataDavid A Jolliffe, Carlos A Camargo, John D Sluyter, et al.
Journal of Neurology|September 28, 2023
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategiesYing Li, Alice Saul, Bruce Taylor, et al.
Brain : a Journal of Neurology|June 27, 2023
The risk of secondary progressive multiple sclerosis is geographically determined but modifiableSifat Sharmin, Izanne Roos, Steve Simpson-Yap, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
The Lancet. Diabetes & Endocrinology|April 2, 2021
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trialsDavid A Jolliffe, Carlos A Camargo, John D Sluyter, et al.
Neurology|October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple SclerosisSteve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trialsDavid A Jolliffe, Carlos A Camargo, John D Sluyter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 SeveritySteve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
The Lancet. Diabetes & Endocrinology|February 24, 2025
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate dataDavid A Jolliffe, Carlos A Camargo, John D Sluyter, et al.
Journal of Neurology|September 28, 2023
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategiesYing Li, Alice Saul, Bruce Taylor, et al.
Brain : a Journal of Neurology|June 27, 2023
The risk of secondary progressive multiple sclerosis is geographically determined but modifiableSifat Sharmin, Izanne Roos, Steve Simpson-Yap, et al.
Pageof 9